Barry Callebaut Aktie WKN: 914661 / ISIN: CH0009002962

Diese Aktie kaufen
mehr Daten anzeigen
Werbung

Times and Sales (XETRA)

ZeitKursUmsatz
Zur Zeit stehen keine Daten zur Verfügung
weiter
Werbung

Aktuelle News zu

05:20 UhrSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sonoma Pharmaceuticals, Inc. - SNOA
05:10 UhrSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA
04:51 UhrGoogle Fotos führt Datenlimit ein - Kostenloser Cloud-Speicher ab Juni 2021 begrenzt
04:49 Uhrdpa-AFX KUNDEN-INFO: Finanzanalysen in den dpa-AFX Diensten
04:31 UhrBirks Group Reports its Mid-Year FY2021 Results
04:31 UhrBirks Group Reports its Mid-Year FY2021 Results
04:30 UhrThe Green Economy: Unlocking a More Sustainable Future in Southeast Asia
04:20 UhrHertz Global Holdings Announces Asset Purchase Agreement With Athene Holding For The Sale Of Donlen Corporation
04:19 UhrNew Report: 4 Key Factors to Successfully Attract and Retain Vietnam's Gen Z in the Workplace
04:06 UhrLONGi liefert 273 MW seiner Solarmodule an Südostasiens größte Solaranlage, Phase I des Xuan Thien Ea Sup Projekts in Dak Lak, Vietnam
04:00 UhrFairchild Medical Center Provides Notice of Data Event
03:58 UhrVirgin aufgepasst: Konkurrierendes Hyperloop-Projekt stellt neuen Geschwindigkeitsrekord auf
03:55 UhrPomerantz Law Firm Announces the Filing of a Class Action against Neovasc Inc. and Certain Officers - NVCN
03:50 UhrFalcon's Creative Group Brings Virtual Worlds to Karate Combat Season 2
03:45 UhrMit Vollgas in den S&P 500 - Was der Indexeinstieg von Tesla für den Index und die Tesla-Aktie bedeutet
03:34 UhrSenhwa Announces Multiple IND Application Submissions to US FDA and Health Canada for the Treatment of Solid Tumors with BRCA2 or PALB2 Mutations
03:32 UhrApproval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for the Treatment of Myelodysplastic Syndrome
03:25 UhrApproval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for the Treatment of Myelodysplastic Syndrome
03:23 UhrPeer-to-Peer lending platform Rai Capital announces its launch in Cambodia, filling the gap for flexible local financing solutions
03:03 UhrT. Rowe Price mit durchwachsenem Ausblick: Anleger sollten ihre Renditeerwartungen langfristig senken
03:00 UhrBasisAI included in Responsible AI Solutions New Tech report by Independent Research Firm
03:00 UhrBasisAI included in Responsible AI Solutions New Tech report by Independent Research Firm
03:00 UhrBasisAI included in Responsible AI Solutions New Tech report by Independent Research Firm
03:00 UhrMetroResidences launches Residential Rentals, rolling out over 1,000 apartments for long-term leases
02:58 UhrWahed Technologies (Wahed) Launches The 1st Active vs Passive Islamic Funds Report for Malaysia
02:47 UhrPalantir-Aktie, CureVac-Aktie, Snowflake-Aktie & Co: Das wurde aus den Börsengängen in 2020
02:30 UhrMaddox Defense Wins Bid to Provide Reliable Quality PPE for the U.S. Government
02:20 UhrEnbridge Inc. to Host Virtual Investor Conference on December 8
02:20 UhrEnbridge Inc. to Host Virtual Investor Conference on December 8
02:15 UhrWeltmeisterschaft der chinesischen Kochkunst „Haday Cup" 2020 im westchinesischen Banan (Chongqing) geht zu Ende
02:11 UhrPinnacle Renewable Energy Provides Update on Operations at its Houston Facility
02:04 UhrSymonite Solutions Creates Hi-Tech Panelised Facade Systems
02:02 UhrHighly Acclaimed Psychologist and Entrepreneur Dr. Yasmin Davidds Partners With Fierce Conversations to Lead Training Sessions Using Innovative 3D Simulations
02:00 UhrUniversity of Minnesota Physicians Provides Notice of Data Security Event
02:00 UhrIAS Expands 'Context Control' Solution in APAC, Adds Bahasa Indonesia and Thai Language Capabilities
02:00 UhrIAS Expands 'Context Control' Solution in APAC, Adds Bahasa Indonesia and Thai Language Capabilities
02:00 UhrDain Leaders visualizes the digital tracking platform for international students made available by the Blockchain technology.
01:55 UhrAUTOCRYPT Launches C-V2X Solution Demonstrating Interoperability with China C-SCMS Standards
01:54 UhrVesta Signs New BTS Lease Agreement With Coppel At Vesta Park Guadalupe In Monterrey, Nuevo Leon
01:54 UhrBlack Friday Deals: Pit Boss Sauce Offers A Wide Range Of Tasty, Flavorful Cajun Hot Sauces
01:41 UhrStoneway Announces Change to Meeting Date and Other Key Dates in Connection with Restructuring Transaction
01:37 UhrLightspeed Announces Closing of Acquisition of ShopKeep
01:37 UhrSHAREHOLDER ALERT: WeissLaw LLP Investigates INSU Acquisition Corp. II
01:37 UhrLightspeed Announces Closing of Acquisition of ShopKeep
01:28 UhrTSX Venture Exchange Stock Maintenance Bulletins
01:28 UhrTSX Venture Exchange Stock Maintenance Bulletins
01:24 UhrChengdu in SW-China richtet Forum zur Innovation in der internationalen Logistik aus
01:20 UhrDie Zukunft des Mittelmeerraums nach der Pandemie
01:19 UhrRenaissance Reports Third Quarter 2020 Results
01:15 UhrCredit Adjustments, Inc. Poised for Great Success When Student Loan Payments Resume in January

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln